FGFR3 and urothelial carcinoma: This receptor could potentially facilitate BoNT/A uptake in the urothelium as it has been shown that FGFR3 is expressed in the urothelium and mutations in the FGFR3 gene contribute to the development of urothelial carcinoma [122].